Recommendations for Clinical Trial Development in Mantle Cell Lymphoma-Reference-Cited by-同舟云学术

Recommendations for Clinical Trial Development in Mantle Cell Lymphoma

Published:2016-12-31 Issue:1 Volume:109 Page:djw263
ISSN:0027-8874
Container-title:Journal of the National Cancer Institute
language:en
Short-container-title:JNCI J Natl Cancer Inst

Author:

Spurgeon Stephen E.,Till Brian G.,Martin Peter,Goy Andre H.,Dreyling Martin P.,Gopal Ajay K.,LeBlanc Michael,Leonard John P.,Friedberg Jonathan W.,Baizer Lawrence,Little Richard F.,Kahl Brad S.,Smith Mitchell R.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Reference96 articles.

1. Incidence trends of mantle cell lymphoma in the United States between 1992 and 2004

2. A revised European-American classification of lymphoid neoplasms: A proposal from the international lymphoma study group;Harris;Blood.,1994

3. Survival trends in mantle cell lymphoma in the United States over 16 years 1992–2007

4. Improvement of Overall Survival in Advanced Stage Mantle Cell Lymphoma

5. Therapy of Mantle Cell Lymphoma: Current Standards and Future Strategies

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CANCER THERAPY BY CYCLIN-DEPENDENT KINASE INHIBITORS (CDKIS): BENCH TO BEDSIDE;EXCLI J;2024

2. Recommendations for cellular and molecular pathology input into clinical trials: a systematic review and meta‐aggregation;The Journal of Pathology: Clinical Research;2021-02-26

3. Management of Drug Resistance in Mantle Cell Lymphoma;Cancers;2020-06-12

4. An open‐label phase 2 trial of entospletinib in indolent non‐Hodgkin lymphoma and mantle cell lymphoma;British Journal of Haematology;2018-09-05

5. Maintenance Therapy in Diffuse Large B Cell Lymphoma and Mantle Cell Lymphoma;Current Treatment Options in Oncology;2018-07-21